| Literature DB >> 34926691 |
W P R T Perera1, Janitha A Liyanage2, K G C Dissanayake3, Hiruni Gunathilaka4, W M T D N Weerakoon2, D N Wanigasekara5, W S K Fernando2, R M H Rajapaksha6, R P Liyanage3, Bingun T Perera2.
Abstract
Viruses are responsible for a variety of human pathogenesis. Owing to the enhancement of the world population, global travel, and rapid urbanization, and infectious outbreaks, a critical threat has been generated to public health, as preventive vaccines and antiviral therapy are not available. Herbal medicines and refined natural products have resources for the development of novel antiviral drugs. These natural agents have shed light on preventive vaccine development and antiviral therapies. This review intends to discuss the antiviral activities of plant extracts and some isolated plant natural products based on mainly preclinical (in vitro and in vivo) studies. Twenty medicinal herbs were selected for the discussion, and those are commonly recognized antiviral medicinal plants in Ayurveda (Zingiber officinale, Caesalpinia bonducella, Allium sativum, Glycyrrhiza glabra, Ferula assafoetida, Gymnema sylvestre, Gossypium herbaceum, Phyllanthus niruri, Trachyspermum ammi, Withania somnifera, Andrographis paniculata, Centella asiatica, Curcuma longa, Woodfordia fruticose, Phyllanthus emblica, Terminalia chebula, Tamarindus indica, Terminalia arjuna, Azadirachta indica, and Ficus religiosa). However, many viruses remain without successful immunization and only a few antiviral drugs have been approved for clinical use. Hence, the development of novel antiviral drugs is much significant and natural products are excellent sources for such drug developments. In this review, we summarize the antiviral actions of selected plant extracts and some isolated natural products of the medicinal herbs.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34926691 PMCID: PMC8674041 DOI: 10.1155/2021/7872406
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Chemical structure of the gingerols, a major phenolic compound that identified as the dominant constituent of both fresh and dried gingers.
Figure 2Chemical structure of the Taepeenin J, cassane-type diterpenes readily found in seeds of Caesalpinia species.
Preclinical investigations of viral inhibition assays of organosulfur compounds which isolate from A. sativum.
| Organosulfur compound | Detection method | Virus species | Antiviral mechanism | Reference |
|---|---|---|---|---|
| Allicin | Direct preinfection incubation and plaque reduction assay | Herpes simplex virus-1 | Disruption of viral envelop and | [ |
|
| ||||
| Alliin | Anti-inflammatory assay | Dengue virus | Inhibition of inflammation via reduction of oxidative stress | [ |
|
| ||||
| Ajoene | Anti-HIV activity | Human immunodeficiency virus-1 | Prevention of induced destructions of CD+ cells | [ |
| HIV-infected platelet aggregation and fusion assays | Human immunodeficiency virus | Inhibition of adhesive bonds and fusion of leukocytes | [ | |
| HIV induced cellular toxicity assay | Human immunodeficiency virus-1 | Inhibition of viral reverse transcriptase and cell attachment | [ | |
|
| ||||
| Allyl methyl thiosulfinate | Direct preinfection and plaque reduction assay | Herpes simplex virus-1 | Disruption of viral envelop and | [ |
|
| ||||
| Diallyl trisulfide | Plaque reduction assay | Human cytomegalovirus; | Inhibit viral DNA synthesis through inhibition of HCMV immediate early antigen expression | [ |
|
| ||||
| Diallyl sulfide and Diallyl disulfide | Oxidative stress and anti-inflammatory assay | Dengue virus | Reduction of oxidative stress | [ |
Figure 318β-glycyrrhetinic acid (18β-GA), the active phytochemicals in licorice which performed antiviral activity against HRSV.
Figure 4Chemical structure of the glycyrrhizin, natural saponin composed in G. glabra root/stem extract.
Figure 5Sesquiterpene cumarines isolated from oligo-gum resin of Ferula assafoetida showed antiviral properties against rhinovirus (HSV).
Figure 6Sesquiterpene cumarines isolated from oligo-gum resin of Ferula assafoetida against showed antiviral properties against influenza A H1N1 virus: (a) 8′-acetoxy-5′S-hydroxyumbelliprenin, (b) methyl galbanate, (c) galbanic acid, and (d) conferol.
Figure 7The structure of gossypol, an active antiviral compound found in the principle pigment of cotton (Gossypium herbaceum).
Figure 8Chemical structure of the repandusinic acid, a hydrolyzable tannin, contains a significant inhibitory effect on HIV-1 reverse transcriptase.
Figure 9Structures of Withaferin A, a steroidal compound present in Withania somnifera.
Figure 10Structure of andrographolide, major phytoconstituent in Andrographis paniculata.
Figure 11Structure of curcumin as the major constituent in C. longa.
Figure 12Structure of 1,2,4,6-tetra-O-galloyl-β-D-glucose, a polyphenolic compound isolated from Phyllanthus emblica.
Figure 13Structure of casuarinin, a hydrolyzable tannin isolated from the Terminalia arjuna bark.
Figure 14Structure of azadirachtin contains in the seed of the Azadirachta indica which recognize as major constituent for anti-intertidal properties.
Summary (phytocompounds and antiviral mechanisms).
| Phytocompound | Medicinal herb | Target viral species | Mechanism |
|---|---|---|---|
| (1) Gingerols |
| HRS virus | N/I |
| (2) Taepeenin j |
| SARS-COV-19 virus | Mitigate cytokine storms by preventing the receptor binding process |
| (3) Allicin |
| Herpes simplex virus-1 | Disruption of viral envelop and cell membrane |
| (4) Alliin and diallyl sulfide |
| Dengue virus | Reduction of oxidative stress |
| (5) Ajoene |
| Human immunodeficiency virus-1 | Inhibition of viral reverse transcriptase and cell attachment |
| (6) Allyl methyl thiosulfinate |
| Herpes simplex virus-1 | Disruption of viral envelop and cell membrane |
| (7) Diallyl trisulfide |
| Human cytomegalovirus; IAV-H1N1 | Inhibit viral DNA synthesis |
| (8) Glycyrrhizin |
| Herpes simplex virus (HSV-1 and HSV-2) and severe acute respiratory syndrome (SARS) coronavirus | Inhibit the plaque formation of herpes simplex virus (HSV-1 and HSV-2) |
| (9) Microlobidene, Farnesiferol C, Farnesiferol B, Kellerin |
| Rhinovirus (HRV-2) | Prevention of rhinovirus adsorption (HRV-2) |
| (10) 8′-acetoxy-5′S-hydroxyumbelliprenin, methyl galbanate, galbanic acid, conferol |
| Influenza A H1N1 virus | N/I |
| (11) Gossypol |
| (HIV-l) human immunodeficiency | Prevented the replication |
| (12) Repandusinic acid |
| (HIV-l) human immunodeficiency | Inhibitory effect on HIV-1 reverse transcriptase |
| (13) Withaferin A |
| Herpes simplex virus | Inhibits herpes simplex virus's DNA polymerases |
| (14) Curcumin |
| Influenza viruses PR8, H1N1, and H6N1 | N/I |
| (15) 1,2,4,6-Tetra-O-galloyl- |
| Herpes simplex virus | Blocking viral attachment and penetration |
| (16) Casuarinin |
| Herpes simplex type 2 viruses (HSV-2) | Inhibition of viral penetration |
N/I: not identified.